Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Adarx Pharmaceuticals Insider Bought Shares Worth $1,045,772, According to a Recent SEC Filing

Adarx Pharmaceuticals Insider Bought Shares Worth $1,045,772, According to a Recent SEC Filing

MT newswireMT newswire2026/09/30 21:32
05:32 PM EDT, 09/30/2026 (MT Newswires) -- Erez Chimovits, Director, on September 28, 2026, executed a purchase for 61,516 shares in Adarx Pharmaceuticals (ADRX) for $1,045,772. Following the Form 4 filing with the SEC, Chimovits has control over a total of 9,292,025 common shares of the company, with 9,292,025 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1802369/000094787126000912/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!